Wednesday, 19 January 2011

Whistleblower exposes GlaxoSmithKline's dangerous practices



Drug company whistle-blower Cheryl Eckard talks about her experience trying to fix problems at GlaxoSmithKline. Her discoveries about the dangerous practices of the company made her a key figure in a federal lawsuit.

Original interview and video.

Mercola's take on Avandia, another dangerous GSK drug.

"...GSK's blockbuster diabetes drug Avandia made headlines again last year when it became clear that the drug not only had major risks, but that GSK kept the dangers of the drug under tight wraps—for a very long time.

As it turns out, GSK spent 11 years covering up trial data that showed that Avandia was a risky drug for the heart—again providing indisputable evidence that the drug paradigm is about money, not health. Avandia topped the list of drugs linked to fatal adverse events in 2009, according to an analysis of U.S. FDA records, with 1,354 deaths reported that year alone. As a result, the FDA recently decided to restrict access to the drug.

In the US, Avandia is now only available to new patients if they are unable to achieve glycemic control using other medications and, in consultation with their health care professional, decide not to take a different drug for medical reasons. Europe decided to ban the drug due to its exaggerated health risks."

"One aspect that truly worries me is that while the criminal cases we've seen in the past several years are related to drugs, many of these companies, including GSK, also produce VACCINES.

And guess what?

They're typically not liable for damages from, or harm done by, contaminated or otherwise dangerous vaccines! We've recently seen evidence of "mistakes" in vaccine manufacturing as well, but vaccine makers are rarely if ever punished for these willful errors and omissions, which should provide you some further food for thought..."

No comments:

Post a Comment